Literature DB >> 15214537

A unifying framework for multi-criteria fluence map optimization models.

H Edwin Romeijn1, James F Dempsey, Jonathan G Li.   

Abstract

Models for finding treatment plans for intensity modulated radiation therapy are usually based on a number of structure-based treatment plan evaluation criteria, which are often conflicting. Rather than formulating a model that a priori quantifies the trade-offs between these criteria, we consider a multi-criteria optimization approach that aims at finding the so-called undominated treatment plans. We present a unifying framework for studying multi-criteria optimization problems for treatment planning that establishes conditions under which treatment plan evaluation criteria can be transformed into convex criteria while preserving the set of undominated treatment plans. Such transformations are identified for many of the criteria that have been proposed to date, establishing equivalences between these criteria. In addition, it is shown that the use of a nonconvex criterion can often be avoided by transformation to an equivalent convex criterion. In particular, we show that models employing criteria such as tumour control probability, normal tissue complication probability, probability of uncomplicated tumour control, as well as sigmoidal transformations of (generalized) equivalent uniform dose are equivalent to models formulated in terms of separable voxel-based criteria that penalize dose in individual voxels.

Entities:  

Mesh:

Year:  2004        PMID: 15214537     DOI: 10.1088/0031-9155/49/10/011

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  14 in total

1.  Intensity modulated radiation therapy with field rotation--a time-varying fractionation study.

Authors:  Delal Dink; Mark P Langer; Ronald L Rardin; Joseph F Pekny; Gintaras V Reklaitis; Behlul Saka
Journal:  Health Care Manag Sci       Date:  2012-01-10

2.  Multicriteria VMAT optimization.

Authors:  David Craft; Dualta McQuaid; Jeremiah Wala; Wei Chen; Ehsan Salari; Thomas Bortfeld
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

3.  Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning.

Authors:  T Long; M Matuszak; M Feng; B A Fraass; R K Ten Haken; H E Romeijn
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

4.  A fast optimization algorithm for multicriteria intensity modulated proton therapy planning.

Authors:  Wei Chen; David Craft; Thomas M Madden; Kewu Zhang; Hanne M Kooy; Gabor T Herman
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

5.  Evaluating target cold spots by the use of tail EUDs.

Authors:  Thomas Bortfeld; David Craft; James F Dempsey; Tarek Halabi; H Edwin Romeijn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-25       Impact factor: 7.038

6.  Simultaneous navigation of multiple Pareto surfaces, with an application to multicriteria IMRT planning with multiple beam angle configurations.

Authors:  David Craft; Michael Monz
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

7.  Calculating and controlling the error of discrete representations of Pareto surfaces in convex multi-criteria optimization.

Authors:  David Craft
Journal:  Phys Med       Date:  2009-12-21       Impact factor: 2.685

8.  Simultaneous beam sampling and aperture shape optimization for SPORT.

Authors:  Masoud Zarepisheh; Ruijiang Li; Yinyu Ye; Lei Xing
Journal:  Med Phys       Date:  2015-02       Impact factor: 4.071

9.  [Constraint priority list-based multi-objective optimization for intensity-modulated radiation therapy].

Authors:  Yan-Hua Mai; Fan-Tu Kong; Yi-Wei Yang; Yong-Bao Li; Ting Song; Ling-Hong Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

Review 10.  Automation in intensity modulated radiotherapy treatment planning-a review of recent innovations.

Authors:  Mohammad Hussein; Ben J M Heijmen; Dirk Verellen; Andrew Nisbet
Journal:  Br J Radiol       Date:  2018-09-04       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.